STIFEL FINANCIAL CORP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$130,000
+4.0%
20,766
-0.5%
0.00%
Q2 2021$125,000
-34.9%
20,866
-31.2%
0.00%
Q1 2021$192,000
+73.0%
30,308
+54.4%
0.00%
Q4 2020$111,000
-6.7%
19,632
-3.8%
0.00%
Q3 2020$119,000
-16.2%
20,414
+3.5%
0.00%
Q2 2020$142,000
+43.4%
19,725
-5.5%
0.00%
Q1 2020$99,000
-65.9%
20,867
-40.1%
0.00%
-100.0%
Q4 2019$290,000
+79.0%
34,854
+59.4%
0.00%
Q3 2019$162,000
-14.3%
21,863
-1.5%
0.00%
Q2 2019$189,000
-18.9%
22,193
-2.7%
0.00%
-100.0%
Q1 2019$233,000
+32.4%
22,816
+2.2%
0.00%0.0%
Q4 2018$176,000
-40.9%
22,314
+30.7%
0.00%0.0%
Q3 2018$298,000
+15.5%
17,077
-36.9%
0.00%0.0%
Q2 2018$258,00027,0550.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders